Report overview
Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.
This report aims to provide a comprehensive presentation of the global market for Testosterone Replacement Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Testosterone Replacement Therapy. This report contains market size and forecasts of Testosterone Replacement Therapy in global, including the following market information:
Global Testosterone Replacement Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Testosterone Replacement Therapy Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Testosterone Replacement Therapy companies in 2022 (%)
The global Testosterone Replacement Therapy market was valued at US$ 1570.7 million in 2022 and is projected to reach US$ 1186.9 million by 2029, at a CAGR of -3.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Testosterone Replacement Therapy key players include AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan) etc. Global top five manufacturers hold a share over 70%. North America is the largest market, with a share over 80%, followed by Europe and Asia (Ex. China) , both have a share over 10% percent.
In terms of product, Gels is the largest segment, with a share over 60%. And in terms of application, the largest application is Clinics, followed by Hospitals.
We surveyed the Testosterone Replacement Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Testosterone Replacement Therapy Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Testosterone Replacement Therapy Market Segment Percentages, by Type, 2022 (%)
Gels
Injections
Patches
Other
Global Testosterone Replacement Therapy Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Testosterone Replacement Therapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Testosterone Replacement Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Testosterone Replacement Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Testosterone Replacement Therapy revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Testosterone Replacement Therapy revenues share in global market, 2022 (%)
Key companies Testosterone Replacement Therapy sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Testosterone Replacement Therapy sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Endo International
Eli lilly
Pfizer
Actavis (Allergan)
Bayer
Novartis
Teva
Mylan
Upsher-Smith
Ferring Pharmaceuticals
Kyowa Kirin
Acerus Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Testosterone Replacement Therapy, market overview.
Chapter 2: Global Testosterone Replacement Therapy market size in revenue and volume.
Chapter 3: Detailed analysis of Testosterone Replacement Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Testosterone Replacement Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Testosterone Replacement Therapy capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
